Supraphysiological levels of magnesium in cardioplegic arrest solutions: is there cause for concern?
Tyers
G F
GF
D000818:Animals; D001639:Bicarbonates / Q000009:adverse effects / Q000627:therapeutic use; D002122:Calcium Chloride / Q000009:adverse effects / Q000627:therapeutic use; D002314:Cardioplegic Solutions / Q000009:adverse effects* / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects*; D006324:Heart Arrest, Induced / Q000379:methods*; D006801:Humans; D008274:Magnesium / Q000009:adverse effects* / Q000627:therapeutic use; D011189:Potassium Chloride / Q000009:adverse effects / Q000627:therapeutic use; D012965:Sodium Chloride / Q000009:adverse effects / Q000627:therapeutic use
D001639:Bicarbonates; D002314:Cardioplegic Solutions; C041711:St. Thomas' Hospital cardioplegic solution; D012965:Sodium Chloride; D011189:Potassium Chloride; D008274:Magnesium; D002122:Calcium Chloride